Infection Surveillance in Intensive Care Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Herlev Hospital.
Recruitment status was  Active, not recruiting
Information provided by:
Herlev Hospital Identifier:
First received: September 12, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted

Purpose of the study is to investigate and quantify known and possible new riskfactors for nosocomiel infection and death in the intensive care setting.

As new riskfactors Mannose Binding Lechtin and Procalcitonin are chosen and compared to established riskfactors.

Cross Infection

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal

Further study details as provided by Herlev Hospital:

Estimated Enrollment: 549
Study Start Date: December 2002
Estimated Study Completion Date: September 2005

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:Admission to ICU -

Exclusion Criteria:Absence of informed consent and age less than 18 years

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00197847

Department of Intensive Care
Copenhagen, Copenhagen Couty, Denmark, DK-2730
Sponsors and Collaborators
Herlev Hospital
Principal Investigator: Dorthe H Olsen, M.D. Department of Intensive Care, Herlev University Hospital
  More Information Identifier: NCT00197847     History of Changes
Other Study ID Numbers: KA 02071 
Study First Received: September 12, 2005
Last Updated: September 12, 2005
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Communicable Diseases
Cross Infection
Disease Attributes
Iatrogenic Disease
Pathologic Processes processed this record on May 30, 2016